Want to Help Advance New Treatments for MMA and PA?

Encourage Your Patients to Join JUMP!

JUMP is a natural history study to understand the disease and treatment experience of patients with methylmalonic acidemia (MMA) and propionic acidemia (PA).  

JUMP is being conducted by rare disease online research platform AllStripes in collaboration with HemoShear Therapeutics. HemoShear is also developing HST5040, an oral small molecule for the treatment of MMA and PA.

Encourage families to sign up! 

AllStripes.com/PA or AllStripes.com/MMA